Expansion of Treatment for Hepatitis C Virus Infection

被引：0

作者：

Katarey, Dev ^{[1
]}

机构：

[1] Royal Sussex Cty Hosp, Brighton, E Sussex, England

来源：

关键词：

D O I：

10.7326/L17-0696

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：457 / 457

页数：1

共 3 条

[1] Gilead Sciences, 2016, HARV US FULL PRESCR
[2] Kattakuzhy S, 2017, ANN INTERN MED, V167, P311, DOI [10.7326/M17-0118, 10.7326/m17-0118]
[3] Glecaprevir and Pibrentasvir for 12 Weeks for Hepatitis C Virus Genotype 1 Infection and Prior Direct-Acting Antiviral Treatment
Poordad, Fred
Felizarta, Franco
Asatryan, Armen
Sulkowski, Mark S.
Reindollar, Robert W.
Landis, Charles S.
Gordon, Stuart C.
Flamm, Steven L.
Fried, Michael W.
Bernstein, David E.
Lin, Chih-Wei
Liu, Ran
Lovell, Sandra S.
Ng, Teresa I.
Kort, Jens
Mensa, Federico J.
[J]. HEPATOLOGY, 2017, 66 (02) : 389 - 397